Home › Esophageal Adenocarcinoma › California › Concord
Esophageal Adenocarcinoma clinical trials in Concord, CA
4 studies for Esophageal Adenocarcinoma are looking for participants at sites in and around Concord (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
RecruitingPhase 2/3
- Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mi away
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
RecruitingPhase 3
- Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mi away
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
RecruitingPhase 3
- Research Site, Walnut Creek · 5 mi away
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
Recruiting
- John Muir Medical Center-Walnut Creek, Walnut Creek · 5 mi away
Esophageal Adenocarcinoma trials in other cities
- New York City, NY18 studies
- Boston, MA13 studies
- Houston, TX12 studies
- Arlington, VA11 studies
- Nashville, TN11 studies
- Durham, NC10 studies
- St. Louis, MO9 studies
- Baldwin Park, CA9 studies
- Rochester, MN9 studies
- Jacksonville, FL9 studies
- Queens, NY9 studies
- Los Angeles, CA9 studies
Other studies in Concord
- Obesity18 studies
- Overweight16 studies
- Non-Small Cell Lung Cancer14 studies
- Major Depressive Disorder12 studies
- Type 2 Diabetes10 studies
- Breast Cancer9 studies
- Lung Cancer9 studies
- Migraine8 studies
- Cancer (all types)7 studies
- Depression6 studies
- Prostate Cancer6 studies
- Diabetes5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.